NasdaqCM - Delayed Quote USD

Acasti Pharma Inc. (ACST)

2.9000 -0.0600 (-2.03%)
At close: April 26 at 4:00 PM EDT
2.9300 +0.03 (+1.03%)
After hours: April 26 at 7:48 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate -0.35-0.27-1.45-1.12
Low Estimate -0.35-0.27-1.45-1.12
High Estimate -0.35-0.27-1.45-1.12
Year Ago EPS ---0.39-4.16-1.45

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD 12/31/2022 3/31/2023 12/31/2023
EPS Est. ---0.66-0.61-0.23
EPS Actual ---0.39-2.84-0.22
Difference --0.27-2.230.01
Surprise % --40.90%-365.60%4.30%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.35-0.27-1.45-1.12
7 Days Ago -0.35-0.27-1.43-1.11
30 Days Ago -0.35-0.27-1.43-1.12
60 Days Ago -0.35-0.27-1.44-1.12
90 Days Ago -0.090-0.34-0.41

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD ACSTIndustrySectorS&P 500
Current Qtr. ------6.50%
Next Qtr. 30.80%----12.00%
Current Year 65.10%----5.30%
Next Year 22.80%----13.10%
Next 5 Years (per annum) ------11.09%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

6.00
6.00 Average
2.9000 Current
6.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Related Tickers